Your browser doesn't support javascript.
loading
In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.
Potucková, Eliska; Roh, Jaroslav; Machácek, Miloslav; Sahni, Sumit; Stariat, Ján; Sesták, Vít; Jansová, Hana; Hasková, Pavlína; Jirkovská, Anna; Vávrová, Katerina; Kovaríková, Petra; Kalinowski, Danuta S; Richardson, Des R; Simunek, Tomás.
Affiliation
  • Potucková E; Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic.
  • Roh J; Department of Inorganic and Organic Chemistry, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic.
  • Machácek M; Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic.
  • Sahni S; Molecular Pharmacology and Pathology Program, Bosch Institute and Department of Pathology, University of Sydney, Sydney, Australia.
  • Stariat J; Department of Pharmaceutical Chemistry and Drug Analysis, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic.
  • Sesták V; Department of Pharmaceutical Chemistry and Drug Analysis, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic.
  • Jansová H; Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic.
  • Hasková P; Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic.
  • Jirkovská A; Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic.
  • Vávrová K; Department of Inorganic and Organic Chemistry, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic.
  • Kovaríková P; Department of Pharmaceutical Chemistry and Drug Analysis, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic.
  • Kalinowski DS; Molecular Pharmacology and Pathology Program, Bosch Institute and Department of Pathology, University of Sydney, Sydney, Australia.
  • Richardson DR; Molecular Pharmacology and Pathology Program, Bosch Institute and Department of Pathology, University of Sydney, Sydney, Australia.
  • Simunek T; Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic.
PLoS One ; 10(10): e0139929, 2015.
Article in En | MEDLINE | ID: mdl-26460540
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiosemicarbazones / Iron Chelating Agents / Metabolic Networks and Pathways / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Document type: Article Affiliation country: Czech Republic Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiosemicarbazones / Iron Chelating Agents / Metabolic Networks and Pathways / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Document type: Article Affiliation country: Czech Republic Country of publication: United States